Search results
Results From The WOW.Com Content Network
Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Public Sector Undertaking (PSU) of the Government of India. Established in 1989 in Bulandshahar , Uttar Pradesh , BIBCOL manufactures oral polio vaccines (OPVs) and other immunisers. [ 1 ]
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
iNCOVACC (codenamed BBV154) [1] is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, [2] [3] American company Precision Virologics [4] [5] and the Washington University School of Medicine in St Louis, Missouri, United States. [6] [7]
Cambridge, MA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal, and parasitic infections, today announced a collaboration with Bharat Biotech for the co-development and commercialization of Alopexx’s proprietary broad-spectrum ...
In December 2020, Ocugen entered into a partnership with Bharat Biotech to co-develop and exclusively commercialise Covaxin in the US market; [16] [17] in June 2021, the partnership was extended to cover Canada. [18] In January 2021, Precisa Medicamentos entered into an agreement with Bharat Biotech to supply Covaxin to Brazil. [19]
Bharat Biotech is also one of the first companies to develop ... Exports of pharmaceuticals products from India increased from US$6.23 billion in 2006–07 to US$8.7 ...
Bharat Biotech is the first in the world to find a vaccine for the Zika virus. [9] [10] Bharat Biotech has delivered over 4 billion vaccines in 123 countries. [4] The vaccine against COVID-19 developed by Bharat Biotech, named Covaxin, was endorsed by the Indian government with an active push by theā Indian Prime Minister Narendra Modi. [11]